NextCell Pharma AB (STO:NXTCL)
Sweden
· Delayed Price · Currency is SEK 1.148
-0.012 (-1.03%)
Apr 29, 2026, 5:29 PM CET
NextCell Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | 2021 - 2017 |
| Cash & Equivalents | 26.03 | 38.72 | 46.79 | 50.03 | 97.12 | Upgrade
|
| Cash & Short-Term Investments | 26.03 | 38.72 | 46.79 | 50.03 | 97.12 | Upgrade
|
| Cash Growth | -32.77% | -17.24% | -6.47% | -48.49% | -30.22% | Upgrade
|
| Accounts Receivable | 3.06 | 3 | 1.67 | 2.35 | 1.78 | Upgrade
|
| Other Receivables | 2.4 | 1.98 | 1.45 | 1.24 | 0.93 | Upgrade
|
| Receivables | 5.47 | 4.98 | 3.12 | 3.58 | 2.71 | Upgrade
|
| Inventory | 0.33 | 0.55 | 0.55 | 0.79 | 0.77 | Upgrade
|
| Prepaid Expenses | 9.57 | 10.15 | 10.17 | 12.87 | 6.16 | Upgrade
|
| Other Current Assets | - | - | 0.05 | 0 | - | Upgrade
|
| Total Current Assets | 41.4 | 54.4 | 60.67 | 67.27 | 106.75 | Upgrade
|
| Property, Plant & Equipment | 14.27 | 14.33 | 12.66 | 13.55 | 9.9 | Upgrade
|
| Long-Term Investments | 7.2 | 6.87 | 6.92 | 6.87 | 6.87 | Upgrade
|
| Other Long-Term Assets | 1.05 | 1.14 | 1.03 | 1.13 | 1.13 | Upgrade
|
| Total Assets | 63.92 | 76.73 | 81.29 | 88.83 | 124.66 | Upgrade
|
| Accounts Payable | 3.34 | 2.69 | 6.16 | 0.89 | 1.92 | Upgrade
|
| Accrued Expenses | 3.38 | 2.25 | 2.49 | 7.65 | 4.16 | Upgrade
|
| Current Unearned Revenue | - | - | 0.25 | 0.2 | - | Upgrade
|
| Other Current Liabilities | 1.31 | 0.49 | 0.98 | 1.35 | 0.85 | Upgrade
|
| Total Current Liabilities | 8.03 | 5.43 | 9.87 | 10.08 | 6.93 | Upgrade
|
| Long-Term Unearned Revenue | 5.29 | 4.92 | 3.82 | 3.02 | 2.18 | Upgrade
|
| Other Long-Term Liabilities | 0 | -0 | -0 | -0 | - | Upgrade
|
| Total Liabilities | 13.32 | 10.34 | 13.69 | 13.1 | 9.12 | Upgrade
|
| Common Stock | 22.84 | 22.84 | 14.98 | 7.05 | 7.05 | Upgrade
|
| Additional Paid-In Capital | 248.41 | 248.41 | 222.33 | 196.43 | 196.43 | Upgrade
|
| Retained Earnings | -220.64 | -204.85 | -169.71 | -127.75 | -87.94 | Upgrade
|
| Shareholders' Equity | 50.6 | 66.39 | 67.6 | 75.73 | 115.54 | Upgrade
|
| Total Liabilities & Equity | 63.92 | 76.73 | 81.29 | 88.83 | 124.66 | Upgrade
|
| Net Cash (Debt) | 26.03 | 38.72 | 46.79 | 50.03 | 97.12 | Upgrade
|
| Net Cash Growth | -32.77% | -17.24% | -6.47% | -48.49% | -30.22% | Upgrade
|
| Net Cash Per Share | - | 0.51 | 1.15 | 1.46 | 2.82 | Upgrade
|
| Filing Date Shares Outstanding | 111.39 | 111.39 | 73.09 | 34.38 | 34.38 | Upgrade
|
| Total Common Shares Outstanding | 111.39 | 111.39 | 73.09 | 34.38 | 34.38 | Upgrade
|
| Working Capital | 33.37 | 48.97 | 50.8 | 57.19 | 99.82 | Upgrade
|
| Book Value Per Share | 0.45 | 0.60 | 0.92 | 2.20 | 3.36 | Upgrade
|
| Tangible Book Value | 50.6 | 66.39 | 67.6 | 75.73 | 115.54 | Upgrade
|
| Tangible Book Value Per Share | 0.45 | 0.60 | 0.92 | 2.20 | 3.36 | Upgrade
|
| Machinery | - | - | 16.04 | 5.22 | 5.15 | Upgrade
|
| Construction In Progress | - | - | - | 11.59 | 7.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.